Diabetes and Stroke Prevention: A Review

被引:32
作者
Hewitt, Jonathan [1 ]
Castilla Guerra, Luis [2 ]
del Carmen Fernandez-Moreno, Maria [3 ]
Sierra, Cristina [4 ]
机构
[1] Cardiff Univ, Geriatr Med, Cardiff CF14 4XY, S Glam, Wales
[2] Univ Seville, Hosp Merced, Dept Internal Med, Seville, Spain
[3] Univ Seville, Hosp Valme, Dept Neurol, Seville, Spain
[4] Univ Barcelona, Hosp Clin, Dept Internal Med, Barcelona, Spain
关键词
D O I
10.1155/2012/673187
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Stroke and diabetes mellitus are two separate conditions which share multiple common threads. Both are increasing in prevalence, both are diseases which affect blood vessels, and both are associated with other vascular risk factors, such as hypertension and dyslipidemia. Abnormal glucose regulation, of which diabetes is one manifestation, is seen in up to two-thirds of people suffering from an acute stroke. Surprisingly, aggressive management of glucose after an acute stroke has not been shown to improve outcome or reduce the incidence of further strokes. More encouragingly, active management of other cardiovascular risk factors has been demonstrated to prevent stroke disease and improve outcome following a stroke in the diabetic person. Hypertension should be treated with a target of 140/80mmHg, as a maximum. The drug of choice would be an ACE inhibitor, although the priority is blood pressure reduction regardless of the medication chosen. Lipids should be treated with a statin whatever the starting cholesterol. Antiplatelet treatment is also essential but there are no specific recommendations for the diabetic person. As these conditions become more prevalent it is imperative that the right treatment is offered for both primary and secondary prevention in diabetic people, in order to prevent disease and minimize disability.
引用
收藏
页数:6
相关论文
共 39 条
  • [1] Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
    Amarenco, Pierre
    Benavente, Oscar
    Goldstein, Larry B.
    Callahan, Alfred, III
    Sillesen, Henrik
    Hennerici, Michael G.
    Gilbert, Steve
    Rudolph, Amy E.
    Simunovic, Lisa
    Zivin, Justin A.
    Welch, K. Michael A.
    [J]. STROKE, 2009, 40 (04) : 1405 - 1409
  • [2] Duration of Diabetes and Risk of Ischemic Stroke The Northern Manhattan Study
    Banerjee, Chirantan
    Moon, Yeseon P.
    Paik, Myunghee C.
    Rundek, Tatjana
    Mora-McLaughlin, Consuelo
    Vieira, Julio R.
    Sacco, Ralph L.
    Elkind, Mitchell S. V.
    [J]. STROKE, 2012, 43 (05) : 1212 - 1217
  • [3] Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders - The Cardiovascular Health Study
    Barzilay, JI
    Spiekerman, CF
    Kuller, LH
    Burke, GL
    Bittner, V
    Gottdiener, JS
    Brancati, FL
    Orchard, TJ
    O'Leary, DH
    Savage, PJ
    [J]. DIABETES CARE, 2001, 24 (07) : 1233 - 1239
  • [4] Reductions in the risks of recurrent stroke in patients with and without diabetes: The PROGRESS trial
    Berthet, K
    Neal, BC
    Chalmers, JP
    Macmahon, SW
    Bousser, M
    Colman, SA
    Woodward, M
    [J]. BLOOD PRESSURE, 2004, 13 (01) : 7 - 13
  • [5] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Bhatt, DL
    Fox, KAA
    Hacke, W
    Berger, PB
    Black, HR
    Boden, WE
    Cacoub, P
    Cohen, EA
    Creager, MA
    Easton, JD
    Flather, MD
    Haffner, SM
    Hamm, CW
    Hankey, GJ
    Johnston, SC
    Mak, KH
    Mas, JL
    Montalescot, G
    Pearson, TA
    Steg, PG
    Steinhubl, SR
    Weber, MA
    Brennan, DM
    Fabry-Ribaudo, L
    Booth, J
    Topol, EJ
    Frye, RL
    Amarenco, P
    Brass, LM
    Buyse, M
    Cohen, LS
    DeMets, DL
    Fuster, V
    Hart, RG
    Marler, JR
    McCarthy, C
    Schoemig, A
    Lincoff, AM
    Brener, SJ
    Sila, CA
    Albuquerque, A
    Aroutiounov, G
    Artemiev, D
    Atkeson, BG
    Bartel, T
    Basart, DCG
    Lima, AB
    Belli, G
    Bordalo e Sa, AL
    Bosch, X
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) : 1706 - 1717
  • [6] Amplified benefit of Clopidogrel versus aspirin in patients with diabetes mellitus
    Bhatt, DL
    Marso, SP
    Hirsch, AT
    Ringleb, PA
    Hacke, W
    Topol, EJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (06) : 625 - +
  • [7] Benefits and Risks for Intensive Glycemic Control in Patients With Diabetes Mellitus
    Blonde, Lawrence
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 343 (01) : 17 - 20
  • [8] Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome
    Callahan, Alfred
    Amarenco, Pierre
    Goldstein, Larry B.
    Sillesen, Henrik
    Messig, Mike
    Samsa, Gregory P.
    Altafullah, Irfan
    Ledbetter, Lucy Y.
    MacLeod, Mary J.
    Scott, Russell
    Hennerici, Michael
    Zivin, Justin A.
    Welch, K. Michael A.
    [J]. ARCHIVES OF NEUROLOGY, 2011, 68 (10) : 1245 - 1251
  • [9] Stroke in diabetic patients: Is it really a macrovascular complication?
    Castilla-Guerra, Luis
    Fernandez-Moreno, Maria del Carmen
    [J]. STROKE, 2007, 38 (10) : E106 - E106
  • [10] Collins R, 2004, LANCET, V363, P757